Brief: Eton Pharmaceuticals Announces Commercial Availability Of Betaine Anhydrous For Oral Solution
10/05/2023 13:51
May 10 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS ANNOUNCES COMMERCIAL AVAILABILITY OF
BETAINE ANHYDROUS FOR ORAL SOLUTION, A GENERIC VERSION OF
CYSTADANE® (BETAINE ANHYDROUS FOR ORAL SOLUTION)
Source text for Eikon: ID:nGNX87Rs80
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer